Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Negrin

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Immunological Reviews|June 1, 1997
Cellular immunotherapy and autologous transplantation for hematologic malignancyK A Margolin, R S Negrin, K K Wong, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Noninvasive assessment of tumor cell proliferation in animal modelsM Edinger, T J Sweeney, A A Tucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphomaS J Horning, R S Negrin, J C Chao, et al.
Bone Marrow Transplantation|January 1, 1994
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantationK G Blume, G D Long, R S Negrin, et al.
Cancer|December 15, 1996
High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myelomaG D Long, N J Chao, W W Hu, et al.
Blood|July 1, 1994
Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cellsA H Galy, S Webb, D Cen, et al.
Leukemia|October 1, 1993
The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrowJ R Schriber, R S Negrin, N J Chao, et al.
Blood|July 1, 1990
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factorR S Negrin, D H Haeuber, A Nagler, et al.
Annals of Internal Medicine|June 15, 1989
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trialR S Negrin, D H Haeuber, A Nagler, et al.
Blood|April 1, 1997
Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donorsC R Kusnierz-Glaz, B J Still, M Amano, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Immunological Reviews|June 1, 1997
Cellular immunotherapy and autologous transplantation for hematologic malignancyK A Margolin, R S Negrin, K K Wong, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Noninvasive assessment of tumor cell proliferation in animal modelsM Edinger, T J Sweeney, A A Tucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphomaS J Horning, R S Negrin, J C Chao, et al.
Bone Marrow Transplantation|January 1, 1994
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantationK G Blume, G D Long, R S Negrin, et al.
Cancer|December 15, 1996
High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myelomaG D Long, N J Chao, W W Hu, et al.
Blood|July 1, 1994
Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cellsA H Galy, S Webb, D Cen, et al.
Leukemia|October 1, 1993
The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrowJ R Schriber, R S Negrin, N J Chao, et al.
Blood|July 1, 1990
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factorR S Negrin, D H Haeuber, A Nagler, et al.
Annals of Internal Medicine|June 15, 1989
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trialR S Negrin, D H Haeuber, A Nagler, et al.
Blood|April 1, 1997
Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donorsC R Kusnierz-Glaz, B J Still, M Amano, et al.
Pageof 10